Ingredient or product comparison
GHK-Cu 50s Age Specific Protocol: Dosing Comparison
25–40 years 1–2mg subcutaneous 6–8 weeks 2–4 weeks Acute tissue repair, wound healing acceleration, collagen maintenance Baseline GHK-Cu levels still adequate; lower doses effective due to higher receptor sensitivity and normal copper transport 50–65 years 1.5
This source-based comparison does not add ratings or recommend a winner.
- 25–40 years
- 1–2mg subcutaneous
- 6–8 weeks
- 2–4 weeks
- Acute tissue repair, wound healing acceleration, collagen maintenance
- Baseline GHK-Cu levels still adequate; lower doses effective due to higher receptor sensitivity and normal copper transport
- 50–65 years
- 1.5–3mg subcutaneous
- 8–12 weeks
- 4–6 weeks
- Collagen density restoration, chronic inflammation modulation, age-related fibroblast activation
- Requires higher doses to overcome reduced ceruloplasmin, hormone-driven collagen suppression, and inflammaging
- 65+ years
- 2–3.5mg subcutaneous
- 10–14 weeks
- Sarcopenia mitigation, osteoarthritis symptom reduction, chronic wound management
- Maximum tolerated dose often needed; longer cycles with extended washouts due to slower peptide clearance rates